Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products.
Financial Results:
Gufic BioSciences Ltd reported Revenues for Q4FY24 of ₹195.00 Crores up from ₹173.00 Crore year on year, a rise of 12.72%.
Total Expenses for Q4FY24 of ₹169.00 Crores up from ₹150.00 Crores year on year, a rise of 12.67%.
Consolidated Net Profit of ₹20.00 Crores up 11.11% from ₹18.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹2.00, up 6.95% from ₹1.87 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.